Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

MannKind Corp. (NASDAQ:MNKD): Bank of America Merrill Lynch’s survey of the market opportunity for MannKind’s Afrezza shows significant use within a year of approval. The firm has increased its peak share estimates, and it keeps its Buy rating on the stock.

http://news.bankrobbersindicators.com/analysts-intel-cash-flow-may-improve-and-4-new-opinions-investors-must-take-a-peek-at/5/

Share
New Message
Please login to post a reply